Why the study?
Do drugs that lower heart rate improve mortality in patients with chronic congestive heart failure?
Do drugs that lower heart rate improve mortality in patients with chronic congestive heart failure?
The mortality benefits of beta-blockers in chronic congestive heart failure are partially attributable to their heart rate-lowering effects.
Answers are grounded in this paper and cite their sources.
Heart rate reduction partly explains beta-blocker benefits in HF; extends mechanistic insights but leaves open dedicated rate-lowering trials.
It has been suggested that drugs for the treatment of heart failure which lower heart rate (HR) have a beneficial effect on mortality, whereas the reverse is true for drugs that increase HR. The objective of this review was to examine the relationship between drug-induced changes in HR and prognosis in heart failure. We reviewed the epidemiological, pathophysiological and clinical evidence of a possible relationship between HR and mortality in heart failure patients. Several heart failure drugs improve patient status and survival without affecting HR. However, part of the beneficial effect of beta-blockers must be attributed to their effect of slowing HR.
No takes yet. Share an insight, caveat, or question.
Henriksen et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: